Omnitude Blockchain Solution for Clinical Trials
Omnitude (ECOM), a UK-based plug and play hybrid blockchain provider, has signed a pharmaceutical commercial contract with Clinical Connex to develop a new blockchain platform to conduct clinical drug trials in the UK and USA. The contract is reported to be worth an estimated $30 million over a 5-year period.